The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial

BACKGROUND: Major depressive disorder (MDD) is a high risk factor for suicide, with up to 20% of MDD patients attempting suicide during their lifetime. Current treatments for MDD are slow onset of action, low efficiency, and the inability to control suicidal behaviors quickly and effectively. Intrav...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haiyan, Lan, Xiaofeng, Wang, Chengyu, Zhang, Fan, Fu, Ling, Li, Weicheng, Ye, Yanxiang, Hu, Zhibo, Chao, Ziyuan, Ning, Yuping, Zhou, Yanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710171/
https://www.ncbi.nlm.nih.gov/pubmed/36451150
http://dx.doi.org/10.1186/s12888-022-04388-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710171/
https://www.ncbi.nlm.nih.gov/pubmed/36451150
http://dx.doi.org/10.1186/s12888-022-04388-y

Ejemplares similares